Glenmark Pharma Share Price History & Returns (2000 To 2024)
Show Table of Contents
Table of Contents
- 1: Glenmark Pharma Share Highlights
- 1.1: 52-Week High Low
- 1.2: All Time High
- 2: Glenmark Pharma Recent Performance
- 3: Glenmark Pharma Share Price Chart From 2000 to 2024
- 4: Glenmark Pharma Share Price History Table From 2000 to 2024
- 5: Analyzing the Impact of Investing in Glenmark Pharma
- 5.1: Glenmark Pharma Share Returns In Last 5 Years
- 5.2: Glenmark Pharma Share Returns In Last 10 Years
- 5.3: Glenmark Pharma Share Returns In Last 15 Years
- 5.4: Glenmark Pharma Share Returns In Last 20 Years
- 6: Glenmark Pharma Returns vs Bank FD Returns
- 7: Short Info About Glenmark Pharma
- 7.1: Glenmark Pharmaceuticals: A Global Pharmaceutical Leader
- 7.2: Additional Resources
Glenmark Pharma Share Highlights
As of Fri 20 Dec 2024, Glenmark Pharma Share price is ₹1,541.65 which is ₹289.30 below 52-week high of ₹1,830.95 and ₹770.65 above 52-week low of ₹771
52-Week High Low
- Glenmark Pharma 52-Week High is ₹1,830.95 occurred on Tue 15 Oct 2024
- Glenmark Pharma 52-Week Low is ₹771 occurred on Thu 15 Feb 2024
All Time High
- The all-time high or the highest price that Glenmark Pharma shares have ever touched was ₹1,830.94 and this occurred on Tue 15 Oct 2024.
- The highest closing price at which Glenmark Pharma shares have ever closed was ₹1,818.15 recorded on Mon 14 Oct 2024.
Glenmark Pharma Recent Performance
Over the past 15 trading days, the value of Glenmark Pharma's stock has increased by ₹19.06 (1.25%).
From 27 Nov 2024 to 20 Dec 2024, it reached a high of ₹1,576.50 and a low of ₹1,446.50.
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Glenmark Pharma Share Price Chart From 2000 to 2024
Glenmark Pharma Share Price History Table From 2000 to 2024
| Year | Glenmark Pharma | YOY Chg% | ↑High - ↓Low |
|---|---|---|---|
| 2024 | ₹1,546.85 | 81.1% |
↑ ₹1,576.5 ↓ ₹1,446.5 |
| 2023 | ₹853.95 | 101.3% |
↑ ₹880 ↓ ₹369.05 |
| 2022 | ₹424.15 | -19.8% |
↑ ₹531.2 ↓ ₹348.5 |
| 2021 | ₹528.54 | 7.1% |
↑ ₹690.95 ↓ ₹442.05 |
| 2020 | ₹493.5 | 42.0% |
↑ ₹573.04 ↓ ₹161.65 |
| 2019 | ₹347.45 | -49.9% |
↑ ₹697.6 ↓ ₹267.25 |
| 2018 | ₹693.05 | 16.5% |
↑ ₹711.9 ↓ ₹493.5 |
| 2017 | ₹594.75 | -33.1% |
↑ ₹972.95 ↓ ₹525.85 |
| 2016 | ₹888.45 | -3.6% |
↑ ₹994 ↓ ₹671.1 |
| 2015 | ₹921.9 | 19.7% |
↑ ₹1,262.9 ↓ ₹702.6 |
| 2014 | ₹770.2 | 44.3% |
↑ ₹841 ↓ ₹496.1 |
| 2013 | ₹533.85 | 1.0% |
↑ ₹613.35 ↓ ₹458 |
| 2012 | ₹528.54 | 80.1% |
↑ ₹550.7 ↓ ₹285 |
| 2011 | ₹293.55 | -18.9% |
↑ ₹372.2 ↓ ₹241.1 |
| 2010 | ₹362.1 | 31.3% |
↑ ₹389.9 ↓ ₹233.35 |
| 2009 | ₹275.85 | -6.8% |
↑ ₹311.5 ↓ ₹119.2 |
| 2008 | ₹296.1 | -50.3% |
↑ ₹736 ↓ ₹211.1 |
| 2007 | ₹596 | 97.8% |
↑ ₹624 ↓ ₹246.5 |
| 2006 | ₹301.35 | 92.2% |
↑ ₹322 ↓ ₹113 |
| 2005 | ₹156.78 | 29.3% |
↑ ₹180 ↓ ₹109.45 |
| 2004 | ₹121.22 | 238.9% |
↑ ₹121.22 ↓ ₹31.75 |
| 2003 | ₹35.77 | 198.3% |
↑ ₹38.56 ↓ ₹10 |
| 2002 | ₹11.99 | 26.7% |
↑ ₹15.55 ↓ ₹9.25 |
| 2001 | ₹9.46 | -7.3% |
↑ ₹11.74 ↓ ₹4.53 |
| 2000 | ₹10.21 | - |
↑ ₹16.2 ↓ ₹9.4 |
Analyzing the Impact of Investing in Glenmark Pharma
Glenmark Pharma share price in 2000 was ₹10.21. If you had invested ₹10,000 in Glenmark Pharma shares in 2000, in 24 years, your investment would have grown to ₹15.15 Lakh by 2024. This represents a positive return of 15,050.3% with a CAGR of 23.3%.
Glenmark Pharma Share Returns In Last 5 Years
- Its highest stock price in the last 5 years was: ₹1,576.50 and lowest was: ₹161.65
- Glenmark Pharma Share price in 2020 was ₹493.50
- By 2024, its share price rose to ₹1,546.85
- It gave a positive return of 213.4% with a CAGR of 25.7% over the last 5 years
- If you had invested ₹10,000 in Glenmark Pharma in 2020 then in 5 years, your investment would have grown to ₹31,344.47 by 2024
Glenmark Pharma Share Returns In Last 10 Years
- Its highest stock price in the last 10 years was: ₹1,576.50 and lowest was: ₹161.65
- Glenmark Pharma Share price in 2015 was ₹921.90
- By 2024, its share price rose to ₹1,546.85
- It gave a positive return of 67.8% with a CAGR of 5.3% over the last 10 years
- If you had invested ₹10,000 in Glenmark Pharma in 2015 then in 10 years, your investment would have grown to ₹16,778.93 by 2024
Glenmark Pharma Share Returns In Last 15 Years
- Its highest stock price in the last 15 years was: ₹1,576.50 and lowest was: ₹161.65
- Glenmark Pharma Share price in 2010 was ₹362.10
- By 2024, its share price rose to ₹1,546.85
- It gave a positive return of 327.2% with a CAGR of 10.2% over the last 15 years
- If you had invested ₹10,000 in Glenmark Pharma in 2010 then in 15 years, your investment would have grown to ₹42,718.86 by 2024
Glenmark Pharma Share Returns In Last 20 Years
- Its highest stock price in the last 20 years was: ₹1,576.50 and lowest was: ₹109.45
- Glenmark Pharma Share price in 2005 was ₹156.78
- By 2024, its share price rose to ₹1,546.85
- It gave a positive return of 886.6% with a CAGR of 12.1% over the last 20 years
- If you had invested ₹10,000 in Glenmark Pharma in 2005 then in 20 years, your investment would have grown to ₹98,663.73 by 2024
Glenmark Pharma Returns vs Bank FD Returns
| Investment Type | Initial Amount | Final Value | Total Returns |
|---|---|---|---|
| Glenmark Pharma Shares | ₹10,000 | ₹15.15 Lakh | 15,050.3% |
| Bank FD (Simple Interest) | ₹10,000 | ₹24,400 | 144.0% |
| Bank FD (Compound Interest) | ₹10,000 | ₹40,489.34 | 304.9% |
Short Info About Glenmark Pharma
Glenmark Pharmaceuticals: A Global Pharmaceutical Leader Established in 1977, Glenmark Pharmaceuticals has emerged as a prominent player in the global pharmaceutical industry. Headquartered in Mumbai, India, the company possesses a substantial market presence across multiple regions, including North America, Latin... Read More
Glenmark Pharmaceuticals: A Global Pharmaceutical Leader
Established in 1977, Glenmark Pharmaceuticals has emerged as a prominent player in the global pharmaceutical industry. Headquartered in Mumbai, India, the company possesses a substantial market presence across multiple regions, including North America, Latin America, Europe, Japan, and international markets.
Glenmark's diversified product range encompasses both branded and generic formulations, specializing in therapeutic areas such as dermatology, respiratory, and oncology.
- Branded Formulations: Glenmark offers a portfolio of innovative branded products, including Ryaltris nasal spray for seasonal allergic rhinitis.
- Generic Formulations: The company's generic formulations provide affordable access to essential medicines in various therapeutic categories.
- Active Pharmaceutical Ingredients: Glenmark manufactures a range of active pharmaceutical ingredients, serving as a key supplier to the global pharmaceutical market.
Glenmark's commitment to innovation and research is evident in its robust product pipeline, which includes several promising drug candidates in Phase 1 and 2 clinical trials.
The company's reputation for excellence and customer focus has garnered widespread recognition within the pharmaceutical industry, solidifying its position as a reliable and trusted partner in healthcare.
Additional Resources
For more insights into Glenmark Pharma, explore these resources:
